Here’s a new $200 million fund Philly healthcare startups should know about

The University City-based 1315 Capital is aiming to make investments of up to $20 million in promising life sciences companies.

June 15, 2016 | Technical.ly by Roberto Torres

As of today, there’s $200 million in fresh investment money looking for a new home. But you have to dream big. The funding is meant for companies that “have the potential to generate $100 million a year in revenue.”

So says University City-based 1315 Capital. The growth-equity firm announced Wednesday the closing of a $200 million fund aimed at commercial-stage pharma, medical and healthcare services companies.

READ MORE

Leave A Comment

All fields required unless stated otherwise.